Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BackgroundBreast augmentation is the most commonly performed cosmetic procedure, and increasingly women in this group present with breast cancer or request risk-reducing surgery, but their optimal management is unclear. The authors explored the clinical and patient-reported outcomes of patients undergoing immediate implant-based breast reconstruction following previous augmentation and compared these with outcomes of patients who had not had cosmetic implants in the Implant Breast Reconstruction Evaluation (iBRA) Study.MethodsPatients undergoing immediate implant-based breast reconstruction were prospectively recruited from breast and plastic surgical units across the United Kingdom. Demographic, operative, and oncologic data, and information regarding complications within 3 postoperative months were collected. Patient-reported outcomes at 18 months were assessed using the BREAST-Q. The clinical and patient-reported outcomes of patients undergoing immediate implant-based breast reconstruction with and without previous breast augmentation were compared.ResultsA total of 2108 women were included in the iBRA Study, of whom 49 had undergone a previous augmentation. Women in the augmentation group were younger (median age, 45 years versus 50 years; p = 0.01), had a lower body mass index (22.8 kg/m2 versus 24.9 kg/m2; p < 0.01), and had smaller tumors (15 mm versus 25 mm; p = 0.01) than patients without augmentation. No differences were seen in operative technique between the groups. Complications at 3 months were similar in both groups and there were no significant differences in patient-reported outcomes at 18 months.ConclusionsThe clinical and patient-reported outcomes of patients undergoing immediate implant-based breast reconstruction following previous augmentation are consistent with those observed in the wider iBRA Study cohort, supporting the safety of this approach.

Original publication

DOI

10.1097/prs.0000000000008713

Type

Journal article

Journal

Plastic and reconstructive surgery

Publication Date

02/2022

Volume

149

Pages

324 - 337

Addresses

From the Department of Plastic Surgery and the Nightingale Centre, Manchester University Hospitals NHS Foundation Trust, Wythenshawe Hospital; Bristol Centre for Surgical Research, Population Health Sciences, Bristol Medical School; University of Manchester, Manchester Academic Health Science Centre; and Bristol Breast Care Centre, North Bristol NHS Trust, Southmead Hospital.

Keywords

Implant Breast Reconstruction Evaluation Study Steering Group and Breast Reconstruction Research Collaborative